1. Home
  2. EZPW vs ABUS Comparison

EZPW vs ABUS Comparison

Compare EZPW & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • ABUS
  • Stock Information
  • Founded
  • EZPW 1989
  • ABUS 2005
  • Country
  • EZPW United States
  • ABUS United States
  • Employees
  • EZPW N/A
  • ABUS N/A
  • Industry
  • EZPW Other Specialty Stores
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZPW Consumer Discretionary
  • ABUS Health Care
  • Exchange
  • EZPW Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • EZPW 809.1M
  • ABUS 670.3M
  • IPO Year
  • EZPW 1991
  • ABUS N/A
  • Fundamental
  • Price
  • EZPW $13.25
  • ABUS $3.43
  • Analyst Decision
  • EZPW Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • EZPW 3
  • ABUS 4
  • Target Price
  • EZPW $19.00
  • ABUS $5.50
  • AVG Volume (30 Days)
  • EZPW 798.7K
  • ABUS 610.0K
  • Earning Date
  • EZPW 07-30-2025
  • ABUS 07-31-2025
  • Dividend Yield
  • EZPW N/A
  • ABUS N/A
  • EPS Growth
  • EZPW 18.94
  • ABUS N/A
  • EPS
  • EZPW 1.19
  • ABUS N/A
  • Revenue
  • EZPW $1,202,458,000.00
  • ABUS $6,403,000.00
  • Revenue This Year
  • EZPW $9.25
  • ABUS $3.35
  • Revenue Next Year
  • EZPW $6.38
  • ABUS N/A
  • P/E Ratio
  • EZPW $11.38
  • ABUS N/A
  • Revenue Growth
  • EZPW 8.14
  • ABUS N/A
  • 52 Week Low
  • EZPW $9.66
  • ABUS $2.71
  • 52 Week High
  • EZPW $16.60
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 40.76
  • ABUS 50.84
  • Support Level
  • EZPW $12.85
  • ABUS $3.46
  • Resistance Level
  • EZPW $13.48
  • ABUS $3.65
  • Average True Range (ATR)
  • EZPW 0.33
  • ABUS 0.12
  • MACD
  • EZPW 0.05
  • ABUS -0.00
  • Stochastic Oscillator
  • EZPW 36.36
  • ABUS 35.29

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: